KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Pacira BioSciences (PCRX) Long-Term Debt Issuances (2017 - 2024)

Pacira BioSciences has reported Long-Term Debt Issuances over the past 5 years, most recently at -$287.5 million for Q4 2024.

  • Quarterly results put Long-Term Debt Issuances at -$287.5 million for Q4 2024, changed N/A from a year ago — trailing twelve months through Dec 2025 was -$287.5 million (changed 0.0% YoY), and the annual figure for FY2020 was $314.7 million, changed.
  • Long-Term Debt Issuances for Q4 2024 was -$287.5 million at Pacira BioSciences, down from $345.0 million in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for PCRX hit a ceiling of -$287.5 million in Q4 2024 and a floor of -$287.5 million in Q4 2024.